Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation

BACKGROUND & AIMS: MiR-33a has emerged as a critical regulator of lipid homeostasis in the liver. Genetic deficiency of miR-33a aggravates liver steatosis in a preclinical model of non-alcoholic fatty liver disease (NAFLD), and relative expression of miR-33a is increased in the livers of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Erhartova, Denisa, Cahova, Monika, Dankova, Helena, Heczkova, Marie, Mikova, Irena, Sticova, Eva, Spicak, Julius, Seda, Ondrej, Trunecka, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839850/
https://www.ncbi.nlm.nih.gov/pubmed/31703079
http://dx.doi.org/10.1371/journal.pone.0224820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839850/
https://www.ncbi.nlm.nih.gov/pubmed/31703079
http://dx.doi.org/10.1371/journal.pone.0224820

Ejemplares similares